FDA faces backlash over approval of genetic test for opioid addiction risk
In a letter to the agency, a group of experts called on the commissioner to revoke its approval, saying the test doesn't work.
SOLVD Health said in its application that AvertD had demonstrated a sensitivity of about 82% and a specificity of about 79%.
Those numbers suggest that roughly 1 in 5 results would be false negatives and roughly 1 in 5 would be false positives.
That doesn't seem very good
Total error rate is about 2/5? That's barely better than a coin flip.
"Oh yes, I just got tested for my potential to become an opioid addict. Give me a second to flip a coin: heads I read the report, tails I toss it in the recycle bin."